News
The department’s newly announced partnerships were part of a weeklong visit that included discussions held at BIO 2025.
By joining the network, NIBRT, Firefinch, and eg technology gain access to what EIT Health referred to as a pan-European ...
BASF announced on June 17, 2025 that it has opened a good manufacturing practice (GMP) facility in Wyandotte, Mich. as part ...
Fabian Gerlinghaus, Alexander Seyf, and Knut Steffensen go behind the headlines and dive into the advanced therapy ecosystem.
The Commissioner’s National Priority Voucher can be used by drug developers to participate in a novel priority program for ...
Chrysalis lists among its partners early-stage biotechnology companies, contract research organizations, top-10 ...
The contest, which aims to accelerate the development of recombinant protein-based oncology therapies, will culminate at CPHI ...
Elkedonia will develop first-in-class Elk1 inhibitors for treatment-resistant depression, targeting neuroplasticity without ...
The collaboration will focus on identifying pre-clinical candidates for high-priority targets, including a small molecule ...
NMPA’s Center for Drug Evaluation accepted Merck KGaA’s application for marketing authorization of pimicotinib as a Class 1 ...
The acquisition boosts BioNTech’s mRNA design and manufacturing capabilities, accelerating development of next-gen cancer ...
PharmTech Group spoke with Andy Burns, vice-president of MDI Business Development at Kindeva, ahead of BIO 2025 to find out ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results